跳至主要内容
临床试验/JPRN-UMIN000023237
JPRN-UMIN000023237已完成3 期

Comparison of resection during distal pancreatectomy of the splenic vein either together with the pancreatic parenchyma or after isolation: A multicentre, prospective, randomized phase III trial (COSMOS-DP trial) - COSMOS-DP trial

Wakayama Medical University0 个研究点目标入组 304 人开始时间: 2016年8月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
304

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (i) Splenic vein-preserving distal pancreatectomy (ii) Superior mesenteric vein or portal vein invasion (iii) Pancreatic trauma (iv) Preoperative inflammatory pancreatic disease (pancreatitis) (v) Requirement of anti-coagulant treatment during or after surgery* (vi) Severe ischemic cardiovascular disease (vii) Liver cirrhosis or active hepatitis (viii) Need for oxygen due to interstitial pneumonia or lung fibrosis (ix) Dialysis due to chronic renal failure (x) Need for surrounding organ resection (stomach, colon, etc.),excluding the left adrenal gland and gall bladder (xi) Active multiple cancer that is thought to influence the occurrence of adverse events (xii) Difficulty with study participation due to psychotic disease or symptoms (xiii) Inappropriate use of the stapler (xiv) Inappropriate for the study objectives * Anti-coagulant treatment at 24 hrs after surgery is allowed.

研究者

相似试验

Comparison of resection during distal pancreatectomy... | 临床试验